IRIS Accounts Production v26.2.0.496 04261332 Board of Directors 1.1.25 31.12.25 31.12.25 dental equipment and sundries supplier. 25 25 false true true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh042613322024-12-31042613322025-12-31042613322025-01-012025-12-31042613322023-12-31042613322024-01-012024-12-31042613322024-12-3104261332ns15:EnglandWales2025-01-012025-12-3104261332ns14:PoundSterling2025-01-012025-12-3104261332ns10:Director12025-01-012025-12-3104261332ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3104261332ns10:MediumEntities2025-01-012025-12-3104261332ns10:Audited2025-01-012025-12-3104261332ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3104261332ns10:Medium-sizedCompaniesRegimeForAccounts2025-01-012025-12-3104261332ns10:FullAccounts2025-01-012025-12-310426133212025-01-012025-12-3104261332ns10:OrdinaryShareClass12025-01-012025-12-3104261332ns10:Director22025-01-012025-12-3104261332ns10:Director32025-01-012025-12-3104261332ns10:Director42025-01-012025-12-3104261332ns10:CompanySecretary12025-01-012025-12-3104261332ns10:RegisteredOffice2025-01-012025-12-3104261332ns5:CurrentFinancialInstruments2025-12-3104261332ns5:CurrentFinancialInstruments2024-12-3104261332ns5:ShareCapital2025-12-3104261332ns5:ShareCapital2024-12-3104261332ns5:RetainedEarningsAccumulatedLosses2025-12-3104261332ns5:RetainedEarningsAccumulatedLosses2024-12-3104261332ns5:ShareCapital2023-12-3104261332ns5:RetainedEarningsAccumulatedLosses2023-12-3104261332ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-3104261332ns5:RetainedEarningsAccumulatedLosses2025-01-012025-12-3104261332ns5:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3104261332ns5:PatentsTrademarksLicencesConcessionsSimilar2025-01-012025-12-3104261332ns5:LeaseholdImprovements2025-01-012025-12-3104261332ns5:PlantMachinery2025-01-012025-12-3104261332ns5:FurnitureFittings2025-01-012025-12-3104261332ns5:ComputerEquipment2025-01-012025-12-3104261332ns5:ReportableOperatingSegment12025-01-012025-12-3104261332ns5:ReportableOperatingSegment12024-01-012024-12-3104261332ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2025-01-012025-12-3104261332ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2024-01-012024-12-3104261332ns15:UnitedKingdom2025-01-012025-12-3104261332ns15:UnitedKingdom2024-01-012024-12-3104261332ns15:Europe2025-01-012025-12-3104261332ns15:Europe2024-01-012024-12-3104261332ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2025-01-012025-12-3104261332ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2024-01-012024-12-3104261332ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2025-01-012025-12-3104261332ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2024-01-012024-12-3104261332ns5:OwnedAssets2025-01-012025-12-3104261332ns5:OwnedAssets2024-01-012024-12-3104261332ns5:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-3104261332132025-01-012025-12-3104261332132024-01-012024-12-3104261332ns10:OrdinaryShareClass12024-01-012024-12-3104261332ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3104261332ns5:PatentsTrademarksLicencesConcessionsSimilar2025-12-3104261332ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3104261332ns5:LeaseholdImprovements2024-12-3104261332ns5:PlantMachinery2024-12-3104261332ns5:FurnitureFittings2024-12-3104261332ns5:ComputerEquipment2024-12-3104261332ns5:LeaseholdImprovements2025-12-3104261332ns5:PlantMachinery2025-12-3104261332ns5:FurnitureFittings2025-12-3104261332ns5:ComputerEquipment2025-12-3104261332ns5:LeaseholdImprovements2024-12-3104261332ns5:PlantMachinery2024-12-3104261332ns5:FurnitureFittings2024-12-3104261332ns5:ComputerEquipment2024-12-3104261332ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3104261332ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3104261332ns5:WithinOneYear2025-12-3104261332ns5:WithinOneYear2024-12-3104261332ns5:BetweenOneFiveYears2025-12-3104261332ns5:BetweenOneFiveYears2024-12-3104261332ns5:MoreThanFiveYears2025-12-3104261332ns5:MoreThanFiveYears2024-12-3104261332ns5:AllPeriods2025-12-3104261332ns5:AllPeriods2024-12-3104261332ns5:AcceleratedTaxDepreciationDeferredTax2025-12-3104261332ns5:AcceleratedTaxDepreciationDeferredTax2024-12-3104261332ns5:DeferredTaxation2024-12-3104261332ns5:DeferredTaxation2025-01-012025-12-3104261332ns5:DeferredTaxation2025-12-3104261332ns10:OrdinaryShareClass12025-12-3104261332ns5:RetainedEarningsAccumulatedLosses2024-12-31
REGISTERED NUMBER: 04261332 (England and Wales)

















Report of the Directors and

Financial Statements for the Year Ended 31 December 2025

for

Top Dental (Products) Limited

Top Dental (Products) Limited (Registered number: 04261332)






Contents of the Financial Statements
for the Year Ended 31 December 2025




Page

Company Information 1

Report of the Directors 2

Report of the Independent Auditors 3

Income Statement 6

Other Comprehensive Income 7

Balance Sheet 8

Statement of Changes in Equity 10

Cash Flow Statement 11

Notes to the Cash Flow Statement 12

Notes to the Financial Statements 13


Top Dental (Products) Limited

Company Information
for the Year Ended 31 December 2025







DIRECTORS: Mr. H C E Karsk
Mrs M U Hallen Tabrizi
Mr S D Rollen
Mrs E R Hansell





SECRETARY: Mr A N Day





REGISTERED OFFICE: Unit 1 Holmfield Industrial Estate
Holmfield
Halifax
HX2 9TN





REGISTERED NUMBER: 04261332 (England and Wales)





AUDITORS: SMH Group Audit
Statutory Auditors
5 Westbrook Court
Sharrow Vale Road
Sheffield
South Yorkshire
S11 8YZ

Top Dental (Products) Limited (Registered number: 04261332)

Report of the Directors
for the Year Ended 31 December 2025

The directors present their report with the financial statements of the company for the year ended 31 December 2025.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2025 to the date of this report.

Mr. H C E Karsk
Mrs M U Hallen Tabrizi
Mr S D Rollen
Mrs E R Hansell

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, SMH Group Audit, will be proposed for re-appointment at the forthcoming Annual General Meeting.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Mr. H C E Karsk - Director


30 March 2026

Report of the Independent Auditors to the Members of
Top Dental (Products) Limited

Opinion
We have audited the financial statements of Top Dental (Products) Limited (the 'company') for the year ended 31 December 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Report of the Directors has been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Top Dental (Products) Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit; or
- the directors were not entitled to take advantage of the small companies' exemption from the requirement to prepare a Strategic Report or in preparing the Report of the Directors.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page two, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Top Dental (Products) Limited


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our assessment of the susceptibility to material misstatement, whether by fraud or error, is made in a risk based approach.

In this approach, laws and regulations applicable to the entity, such as the Companies Act 2006, United Kingdom Generally Accepted Accounting Practice including Financial Reporting Standard 102, the relevant tax compliance regulations within the UK, employment law, and Health and Safety law is considered, and the policies and controls the entity has in place to comply with these laws are reviewed, by discussion, reviews of correspondence and registrations monitored by external bodies. The engagement team remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

Policies and controls relating to the risk of material misstatement as a result of fraud are also considered. These are assessed by obtaining an understanding of the company's operations and control environment. The policies and controls have been reviewed by discussion, review and sample testing of accounting entries, challenging assumptions and judgements, reviewing and evaluating related parties transactions, and wider background searches. Testing of income recognition and cut off, along with testing of inventory valuation is also completed where the documentation has been available.

We have ensured that the engagement team have appropriate levels of competence and experience to effectively monitor these risks and carry out work relevant to our assessment of each risk, including consideration of the industry the company operates in and its size and complexity.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




James Salim FCCA (Senior Statutory Auditor)
for and on behalf of SMH Group Audit
Statutory Auditors
5 Westbrook Court
Sharrow Vale Road
Sheffield
South Yorkshire
S11 8YZ

4 September 2026

Top Dental (Products) Limited (Registered number: 04261332)

Income Statement
for the Year Ended 31 December 2025

2025 2024
Notes £    £   

TURNOVER 3 6,934,456 6,111,315

Cost of sales 4,142,874 3,824,822
GROSS PROFIT 2,791,582 2,286,493

Administrative expenses 1,519,960 1,611,004
1,271,622 675,489

Other operating income 6,907 (4,353 )
OPERATING PROFIT 5 1,278,529 671,136

Interest receivable and similar income 41,947 51,378
1,320,476 722,514

Interest payable and similar expenses 6 - 17,028
PROFIT BEFORE TAXATION 1,320,476 705,486

Tax on profit 7 340,334 188,254
PROFIT FOR THE FINANCIAL YEAR 980,142 517,232

Top Dental (Products) Limited (Registered number: 04261332)

Other Comprehensive Income
for the Year Ended 31 December 2025

2025 2024
Notes £    £   

PROFIT FOR THE YEAR 980,142 517,232


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE
YEAR

980,142

517,232

Top Dental (Products) Limited (Registered number: 04261332)

Balance Sheet
31 December 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 395,418 225,683
Tangible assets 10 508,349 484,603
903,767 710,286

CURRENT ASSETS
Stocks 11 329,016 427,329
Debtors 12 741,875 737,980
Cash at bank and in hand 1,275,586 1,250,124
2,346,477 2,415,433
CREDITORS
Amounts falling due within one year 13 749,757 616,035
NET CURRENT ASSETS 1,596,720 1,799,398
TOTAL ASSETS LESS CURRENT LIABILITIES 2,500,487 2,509,684

PROVISIONS FOR LIABILITIES 15 72,552 61,891
NET ASSETS 2,427,935 2,447,793

CAPITAL AND RESERVES
Called up share capital 16 100 100
Retained earnings 17 2,427,835 2,447,693
SHAREHOLDERS' FUNDS 2,427,935 2,447,793

Top Dental (Products) Limited (Registered number: 04261332)

Balance Sheet - continued
31 December 2025



The financial statements were approved by the Board of Directors and authorised for issue on 30 March 2026 and were signed on its behalf by:





Mr. H C E Karsk - Director


Top Dental (Products) Limited (Registered number: 04261332)

Statement of Changes in Equity
for the Year Ended 31 December 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 January 2024 100 1,930,461 1,930,561

Changes in equity
Total comprehensive income - 517,232 517,232
Balance at 31 December 2024 100 2,447,693 2,447,793

Changes in equity
Dividends - (1,000,000 ) (1,000,000 )
Total comprehensive income - 980,142 980,142
Balance at 31 December 2025 100 2,427,835 2,427,935

Top Dental (Products) Limited (Registered number: 04261332)

Cash Flow Statement
for the Year Ended 31 December 2025

2025 2024
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 1,601,142 836,231
Finance costs paid - (17,028 )
Tax paid (321,199 ) (182,594 )
Net cash from operating activities 1,279,943 636,609

Cash flows from investing activities
Purchase of intangible fixed assets (203,123 ) (23,152 )
Purchase of tangible fixed assets (93,305 ) (343,170 )
Sale of tangible fixed assets - 44,723
Interest received 41,947 51,173
Net cash from investing activities (254,481 ) (270,426 )

Cash flows from financing activities
Capital repayments in year - (66,198 )
Equity dividends paid (1,000,000 ) (423,036 )
Net cash from financing activities (1,000,000 ) (489,234 )

Increase/(decrease) in cash and cash equivalents 25,462 (123,051 )
Cash and cash equivalents at beginning of
year

2

1,250,124

1,373,175

Cash and cash equivalents at end of year 2 1,275,586 1,250,124

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Cash Flow Statement
for the Year Ended 31 December 2025

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2025 2024
£    £   
Profit before taxation 1,320,476 705,486
Depreciation charges 104,148 94,148
Loss on disposal of fixed assets - 113,482
Finance costs - 17,028
Finance income (41,947 ) (51,378 )
1,382,677 878,766
Decrease in stocks 98,313 10,281
Increase in trade and other debtors (3,895 ) (50,019 )
Increase/(decrease) in trade and other creditors 124,047 (2,797 )
Cash generated from operations 1,601,142 836,231

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 December 2025
31/12/25 1/1/25
£    £   
Cash and cash equivalents 1,275,586 1,250,124
Year ended 31 December 2024
31/12/24 1/1/24
£    £   
Cash and cash equivalents 1,250,124 1,373,175


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1/1/25 Cash flow At 31/12/25
£    £    £   
Net cash
Cash at bank and in hand 1,250,124 25,462 1,275,586
1,250,124 25,462 1,275,586
Total 1,250,124 25,462 1,275,586

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements
for the Year Ended 31 December 2025

1. STATUTORY INFORMATION

Top Dental (Products) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - in accordance with the property
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 15% on reducing balance
Computer equipment - Straight line over 3 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Financial assets are recognised in the company's statement of financial position when the company becomes
party to the contractual provisions of the instrument.
Basic financial assets, which include trade and other receivables, amounts owed from group undertakings and
cash and bank balances, are initially measured at fair value and are subsequently carried at amortised cost
using the effective interest method less any allowance for expected credit losses. Trade receivables are
generally due for settlement within 30 days.


Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
The company leases equipment. Rental contracts are typically made for fixed periods of 5 years but may have extension options.
Contracts may contain both lease and non-lease components. The company allocates the consideration in the contract to the lease and non-lease components based on their relative stand-alone prices.
Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions.
The lease agreements do not impose any covenants other than the security interests in the leased assets
that are held by the lessor. Leased assets may not be used as security for borrowing purposes.
Until the 2022 financial year, leases of plant and equipment were classified as either finance leases or operating leases.

From 1 January 2023, leases are recognised as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the company.
Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities
include the net present value of the following lease payments:
o Fixed payments (including in-substance fixed payments), less any lease incentives receivable;
o Variable lease payments that are based on an index or a rate, initially measured using the index or rate as
at the commencement date;
o Amounts expected to be payable by the company under residual value guarantees;
o The exercise price of a purchase option if the company is reasonably certain to exercise that option; and
o Payments of penalties for terminating the lease, if the lease term reflects the company exercising that
option.
Lease payments to be made under reasonably certain extension options are also included in the
measurement of the liability.
The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily
determined, which is generally the case for leases in the company, the lessee's incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment with similar terms, security and conditions.
Lease payments are allocated between principal and finance cost. The finance cost is charged to profit or
loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period.
Right-of-use assets are measured at cost comprising the following:
o The amount of the initial measurement of lease liability;
o Any lease payments made at or before the commencement date less any lease incentives received;
o Any initial direct costs; and
o Restoration costs.
Right-of-use assets are generally depreciated over the shorter of the asset's useful life and the lease term on a straight-line basis. If the company is reasonably certain to exercise a purchase option, the right-of-use
asset is depreciated over the underlying asset's useful life.


Lease accounting
The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily
determined, which is generally the case for leases in the company, the lessee's incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment with similar terms, security and conditions.
o To determine the incremental borrowing rate, the company:
o Where possible, uses recent third-party financing received by the individual lessee as a starting point,
adjusted to reflect changes in financing conditions since third party financing was received;
o Uses a build-up approach that starts with a risk-free interest rate adjusted for credit risk for leases held by
the company, which does not have recent third party financing; and
o Makes adjustments specific to the lease, e.g. term, currency and security.

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

2. ACCOUNTING POLICIES - continued
The company used an average borrowing rates of 1.7% across all leases.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. TURNOVER

The turnover and profit before taxation are attributable to the principal activities of the company.

An analysis of turnover by class of business is given below:

2025 2024
£    £   
Dental Wholesale 6,934,456 6,111,315
6,934,456 6,111,315

An analysis of turnover by geographical market is given below:

2025 2024
£    £   
United Kingdom 5,254,946 4,798,861
Europe 1,292,381 884,119
Rest of the world 387,129 428,335
6,934,456 6,111,315

4. EMPLOYEES AND DIRECTORS

20252024
£   £   
Wages and salaries953,452827,726
Social security costs106,51079,810
Other pension costs20,11622,355
1,080,078929,891

The average number of employees during the year was as follows:
20252024
Sales42
Administration710
Research & Development11
Production1312
2525

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

2025 2024
£    £   
Directors' remuneration 105,357 81,372
Directors' pension contributions to money purchase schemes 1,321 1,321

5. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

2025 2024
£    £   
Hire of plant and machinery 17,463 17,681
Depreciation - owned assets 69,559 62,509
Loss on disposal of fixed assets - 113,482
Patents and licences amortisation 33,388 31,639
Auditors' remuneration 12,000 6,000
Foreign exchange differences (6,907 ) 4,353

6. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Finance Charges - 17,028

7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax 330,005 154,131

Deferred tax 10,329 34,123
Tax on profit 340,334 188,254

UK corporation tax has been charged at 25% .

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

7. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
Profit before tax 1,320,476 705,486
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2024 - 25%)

330,119

176,372

Effects of:
Expenses not deductible for tax purposes 251 35
Capital allowances in excess of depreciation (3,846 ) (11,933 )
Adjustments to tax charge in respect of previous periods 4,939 (1,272 )
Deferred Tax 10,661 34,123
Unrealised gain/finance lease (1,790 ) (9,071 )
Total tax charge 340,334 188,254

8. DIVIDENDS
2025 2024
£    £   
Interim 1,000,000 -

9. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 January 2025 334,359
Additions 203,123
At 31 December 2025 537,482
AMORTISATION
At 1 January 2025 108,676
Amortisation for year 33,388
At 31 December 2025 142,064
NET BOOK VALUE
At 31 December 2025 395,418
At 31 December 2024 225,683

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

10. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 January 2025 275,155 548,754 2,500 18,915 845,324
Additions 14,100 72,799 - 6,406 93,305
At 31 December 2025 289,255 621,553 2,500 25,321 938,629
DEPRECIATION
At 1 January 2025 10,411 333,823 106 16,381 360,721
Charge for year 28,496 37,849 358 2,856 69,559
At 31 December 2025 38,907 371,672 464 19,237 430,280
NET BOOK VALUE
At 31 December 2025 250,348 249,881 2,036 6,084 508,349
At 31 December 2024 264,744 214,931 2,394 2,534 484,603

11. STOCKS
2025 2024
£    £   
Stocks 329,016 427,329

12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 622,670 643,424
Other debtors - 23,630
Prepayments 119,205 70,926
741,875 737,980

13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 472,938 424,264
Tax 6,999 (2,676 )
Social security and other taxes 24,813 20,426
VAT 68,750 52,016
Other creditors 4,052 11,053
Accrued expenses 172,205 110,952
749,757 616,035

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

14. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2025 2024
£    £   
Within one year 115,000 115,000
Between one and five years 460,000 460,000
In more than five years 383,333 498,333
958,333 1,073,333

15. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax
Accelerated capital allowances 72,552 61,891

Deferred
tax
£   
Balance at 1 January 2025 61,891
Provided during year 10,661
Balance at 31 December 2025 72,552

16. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary £1 100 100

17. RESERVES
Retained
earnings
£   

At 1 January 2025 2,447,693
Profit for the year 980,142
Dividends (1,000,000 )
At 31 December 2025 2,427,835

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

18. ULTIMATE PARENT COMPANY

The company's ultimate parent company is Carl Bennet AB, a company incorporated in Sweden.

The largest group of which the company is a member and for which consolidated group financial statements are prepared is Carl Bennet AB. The principle place of business is Box 10035, S-434 21 Kungsbacka, Sweden.

The smallest group of which the company is a member and for which consolidated group financial statements are prepared is Lifco AB, a company incorporated in Sweden. The principle place of business is Verkmöstraregatan 1, SE-745 85 Enköpitig, Sweden.

19. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Carl Bennet by virtue of his controlling shareholdings within Carl Bennet AB